Stay updated on PD-1 Antibody and COX Inhibitor in Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the PD-1 Antibody and COX Inhibitor in Colorectal Cancer Clinical Trial page.

Latest updates to the PD-1 Antibody and COX Inhibitor in Colorectal Cancer Clinical Trial page
- ChecktodayChange DetectedThe ClinicalTrials.gov site revision identifier changes from v3.8.0 to v3.8.1; the study record content remains unchanged.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe record describes a Phase 2 study of PD-1 antibody combined with a COX inhibitor for colorectal cancer and provides details for prospective participants, including eligibility, recruiting locations, and study measures.SummaryDifference49%

- Check21 days agoChange DetectedThe displayed site revision changed from v3.7.2 to v3.8.0; the study page still shows a 403 Forbidden error.SummaryDifference0.2%

- Check28 days agoChange DetectedThe page displays details for a phase 2 study of PD-1 antibody combined with a COX inhibitor for colorectal cancer, including its study design, eligibility criteria, recruiting locations, and outcome measures.SummaryDifference51%

- Check35 days agoChange DetectedThe site footer revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check42 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

Stay in the know with updates to PD-1 Antibody and COX Inhibitor in Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-1 Antibody and COX Inhibitor in Colorectal Cancer Clinical Trial page.